Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Shareholder vote results
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Planned sale Director sold 599 shares at $85.47 ($51,197)
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 4 Planned sale EVP, CFO & CBO sold 8,224 shares at $89.84 ($738,844)
  14. 144 Insider Sale of Securities
  15. ARS Other Annual Report to Security Holders
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 4 Planned sale EVP, CFO & CBO sold 114,367 shares at an average $83.00 ($9,492,596)
  19. 4 Planned sale Director sold 599 shares at $80.11 ($47,986)
  20. 144 Insider Sale of Securities

Page 3 of 33 · 659 filings